ASHG and Mayo Clinic collaborate to facilitate genetic and genomic education

The American Society of Human Genetics (ASHG) and Mayo Clinic Center for Individualized Medicine (CIM) announced today a formal collaboration under which the two organizations will facilitate the use of genomics in medicine through the education of health professionals.

"Genetics and genomics are evolving rapidly and reshaping significant areas of the healthcare landscape and medical education," says Joseph McInerney, executive vice president ASHG. "To keep pace with these developments and translate them into healthcare, learners require accurate, current, and clinically useful information conveyed through high-quality educational products and programs," says McInerney.

"As the individuals conducting research and implementing findings in the clinic, Mayo Clinic and ASHG members are particularly well suited to advancing genetic and genomic literacy at this significant inflection point in medical history," says Keith Stewart, M.B., Ch.B., Carlson and Nelson Endowed Director, CIM, and Vasek and Anna Maria Polak Professor of Cancer Research. "By combining the expertise of our organizations and leveraging our resources collaboratively, we hope to fill this need and improve health outcomes."

The first joint ASHG-CIM educational program, targeted to OB-GYNs and related health professionals, will address the use of prenatal cell-free DNA (cfDNA) screening in pregnant women. Analysis of cfDNA provides a method of non-invasive prenatal genetic screening by isolating DNA in a pregnant woman's blood.

"Prenatal genetics is a rapidly moving area with unique clinical and ethical challenges. If we can help providers and patients have more comprehensive conversations around their prenatal screening and testing options, families can make the informed choices that are right for them," says Megan Allyse, Ph.D., assistant professor, Mayo Clinic Biomedical Ethics Program.

"CfDNA testing has been marketed heavily by test manufacturers and rapidly adopted by clinicians, despite lingering concerns about inappropriate use and confusion about the interpretation of test results and how they should be communicated to patients," added Michael Dougherty, Ph.D., director of education, ASHG. A series of short online modules and point-of-care tools produced by ASHG and CIM will help health professionals better integrate this genomic technology into their practices.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI voice agents helped improve accuracy of blood pressure measurements in older adults